Technology Commercialization Office

Showing 2 result(s) for "Animal Therapeutics"



Novel engineered probiotic that competes specifically with the pathogen Salmonella for vital nutrients in the inflamed intestine of humans and livestock to prevent or treat infection.

A cultivable porcine deltacoronavirus to act as a stepping stone for porcine deltacoronavirus vaccine development.